Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 55150-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55150-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Zoledronic Acid Fig1)

Figure 1 (Zoledronic Acid Fig1)
The text describes a figure showing the proportion of complete responders by day 10 in two different studies involving Zoledronic Acid and Pamidronate. The figure displays a graph with percentages of complete responders on the y-axis and the days on the x-axis. The pooled HCM studies show that the Zoledronic Acid group had a 100% complete response rate compared to 80% in the Pamidronate group. There was also a statistically significant difference between the two groups (P=0.002).*
FDA Label Image

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))
This text is a description of a pharmaceutical product. The product is a sterile, non-pyrogenic solution that comes in a 5mL single-dose vial with NDC code 55150-266-05. It is for intravenous infusion only after dilution, as the dose must be diluted. It should not be mixed with calcium-containing solutions, such as zoledronic infusion solutions. The product is not for direct injection and must be discarded if unused. It is manufactured in India for AuroMedics Pharma LLC in E. Windsor, NJ. The solution has 3% of 4mg per 5mL and a concentration of 0.08mg/mL. It should be stored at room temperature between 20° to 25°C (68° to 77°F) and the unused portions should be discarded.*
FDA Label Image

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))
This is a medication label for a single-dose vial of Zoledronic Acid Injection, which can be used for intravenous infusion after dilution. The medication must not be administered directly and must be diluted before use. The package comes in a 5mL vial, and any unused portion must be discarded. Dosage information is provided, as well as the NDC number for prescription purposes. Some portions of the text are not legible due to issues.*
FDA Label Image

Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)

Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.